Dr. Michael Tuttle

New York, USA

Dr R Michael Tuttle, an Endocrinologist, Professor of Medicine, and Acting Chief of the Endocrinology Service at Memorial Sloan Kettering Cancer Center in New York, designed and validated the first real time risk assessment model for thyroid cancer management in which individual risk estimates are modified over time as a function of response to initial therapy. His research continues to center on important management aspects of thyroid cancer including efforts to better define of risk of recurrence, risk of death, and the potential role for observation in low risk thyroid cancer.